Home  >  News
you can get e-magazine links on WhatsApp.Click here
Medical Device + Font Resize -

CryoLife's Sologrip minimally invasive laser fiber-optic delivery system gets US FDA premarket approval

Saturday, July 13, 2013, 14:00 Hrs  [IST]

CryoLife, Inc., a leading tissue processing and medical device company, has received US Food and Drug Administration (FDA) premarket approval for its new Sologrip minimally invasive laser fiber-optic delivery system. The Sologrip delivery system is a single-use, disposable handset designed for use with the company's Cardiogenesis transmyocardial revascularization (TMR) system.

"We are pleased to receive FDA approval for our updated Sologrip handset. We believe it will be well received by our customers and we look forward to continuing our efforts to increase adoption of this important treatment option for patients with angina," said Steven G Anderson, chairman, president and CEO of CryoLife.

CryoLife's subsidiary, Cardiogenesis Corporation, specializes in the treatment of cardiovascular disease and is a leader in devices that treat severe angina.  Its market leading YAG laser system and single use fiber-optic delivery systems are used to perform an FDA-cleared surgical procedure known as TMR, which treats patients with angina that is not responsive to standard medications. Patients undergoing TMR treatment with Cardiogenesis products have been shown to have angina improvement, longer event-free survival, reduction in cardiac related hospitalizations, and increased exercise tolerance.

CryoLife, Inc. is a leader in the processing and distribution of implantable living human tissues for use in cardiac and vascular surgeries throughout the US, certain countries in Europe, and Canada.


* Name :     
* Email :    
  Website :  
Copyright © 2016 Saffron Media Pvt. Ltd |